Press releases

and Washington, D.C. (October 20, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced nine-month sub-population data from its TAXUS V clinical trial that further supports the...

and Washington, D.C. (October 19, 2005) -- Boston Scientific Corporation (NYSE: BSX) was recognized by physicians as a leader in the pursuit of evidence-based medicine through increased use of...

and Washington, D.C. (October 18, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced follow-up data supporting excellent long-term safety and efficacy from four of its TAXUS...

(October, 17, 2005) -- Boston Scientific Corporation (NYSE: BSX) today presented data from its BEACH clinical trial, which was designed to evaluate the benefits of carotid artery stenting (CAS) in...

, and Washington, D.C. (October 17, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the combined results from the BLAZE and BLAZE II registries showing that its...

(October 14, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for its third quarter ended September 30, 2005 and provided revised revenue and earnings-per-share...

(October 13, 2005) -- Boston Scientific Corporation (NYSE: BSX) today introduced a new program that will offer participating medical centers in the United States a TAXUS® Express2™ stent system...

(October 13, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that a Dutch appeals court yesterday overturned a lower court ruling and reinstated an injunction against the...

(October 10, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company

(October 7, 2005) -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the third quarter ended September 30, 2005 on Friday, October 14,...

(October 4, 2005)

(October 3, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today the grand opening of its new Maple Grove, Minnesota Research and Development facility, which includes several...

(September 19, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today the grand opening of its new Marlborough, Massachusetts office complex, which serves as the new headquarters for...

(September 16, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Flextome™ Cutting...

(September 14, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that its Wayne, New Jersey manufacturing facility has been named one of the 10 best plants in North America by...

(September 13, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has received CE Mark for the Precision™ Spinal Cord Stimulation (SCS) system, Europe

(September 13, 2005) -- Boston Scientific Corporation (NYSE: BSX) today welcomed an article in the Journal of the American Medical Association (JAMA) on the TAXUS V clinical trial that found the TAXUS

(September 8, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has received CE Mark for its TAXUS® Liberté™ paclitaxel-eluting stent system, the world

(September 8, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that three of its drug-eluting stent clinical trials have been recognized as meeting the treatment guidelines of...

(September 7, 2005) -- Boston Scientific Corporation (NYSE: BSX) today commented on its third quarter performance. Speaking at the 2005 Thomas Weisel Partners Healthcare Conference in Boston,...

(September 6, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bear Stearns 18th Annual Healthcare Conference, which is being held September 12 and 13 in New...

(September 1, 2005)

(September 1, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2005 Thomas Weisel Partners Healthcare Conference, which is being held September 7 - 9 in...

(August 16, 2005)

(August 9, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has granted a Humanitarian Device Exemption (HDE) approval for the...

(August 2, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the initial activation of bilateral cochlear implants for 14-month-old identical-twin girls at the California Ear...

(July 28, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has received the 2005 Best Practices in Logistics Management Gold Award from Logistics Management magazine, a...

(July 19, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for its second quarter ended June 30, 2005. Highlights: Net sales of $1.6 billion, an increase of 11...

(July 11, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that physicians have implanted the 1,000th Precision™ Spinal Cord Stimulation System for the treatment of chronic...

(July 8, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the U.S. launch of its Matrix2™ 360o Detachable Coils, which have been cleared by the U.S. Food and Drug...

(July 7, 2005) -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the second quarter ended June 30, 2005 on Tuesday, July 19, at 11:00...

(July 1, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that a U.S. District Court jury in Delaware found that Johnson & Johnson's (NYSE: JNJ) CYPHER® drug-eluting stent...

(June 27, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it is voluntarily recalling worldwide all Hemashield® VANTAGE™ Vascular Grafts, which are used in peripheral...

(June 24, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a civil settlement agreement with the U.S. Department of Justice regarding the Department's...

(June 21, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that a jury in a patent infringement case in U.S. District Court in Delaware brought by Johnson & Johnson (NYSE: JNJ)...

(June 20, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has completed enrollment in the transitional phase of the world's largest drug-eluting stent registry. The...

(June 14, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has completed the final phase of the acquisition of Rubicon Medical Corporation (OTC BB: RMDC). Boston...

(June 9, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in Goldman Sachs' 25th Annual Healthcare Conference, which is being held June 13 -16 in Dana Point, CA....

(June 9, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that a Dutch court has ruled that Cordis Europa N.V. ("Cordis"), a subsidiary of Johnson & Johnson (NYSE: JNJ),...

(June 2, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the completion of the cash tender offer for any and all outstanding shares of common stock of Rubicon Medical...

(June 1, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that Lucia Luce Quinn has been appointed Executive Vice President of Human Resources. She will be responsible for...

and Paris, France (May 26, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has enrolled its 400th patient in the world

and Paris, France (May 25, 2005) -- Boston Scientific Corporation (NYSE: BSX) today provided updated financial estimates for 2005. The Company announced the estimates at a meeting of financial...

and Paris, France (May 25, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced nine-month sub-population data from its TAXUS V clinical trial that further supports the efficacy of...

and Paris, France (May 25, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced thirty-day safety data from its ATLAS clinical trial. ATLAS is the first trial using Boston...

and Paris, France (May 25, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced results from its ARRIVE and Milestone II registries. The results were announced during a symposia...

and Paris, France (May 24, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced two-year follow-up data from its TAXUS VI clinical trial. The data demonstrated that the safety and...

and Paris, France (May 24, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced intravascular ultrasound (IVUS) follow-up data from its TAXUS V clinical trial, supporting the safety...

and Newton, MA (May 23, 2005) -- Boston Scientific Corporation (NYSE: BSX) and Aspect Medical Systems, Inc. (Nasdaq: ASPM) today announced a strategic alliance in which Boston Scientific will...